Advanced search
Publication Cover
Therapeutics and Clinical Risk Management Volume 15, 2019 - Issue
Submit an article Journal homepage
98
Views
6
CrossRef citations to date
0
Altmetric
Case Report

Eosinophilic Pneumonia Associated With Natalizumab In A Patient With Multiple Sclerosis: A Case Report And Literature Review

Yuichiro Yasuda1 Division of Respiratory Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe, Hyogo650-0017, Japan
,
Tatsuya Nagano1 Division of Respiratory Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe, Hyogo650-0017, JapanCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-0790-5139
ORCID Icon,
Motoko Tachihara1 Division of Respiratory Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe, Hyogo650-0017, Japan
,
Norio Chihara2 Division of Neurology, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe, Hyogo650-0017, Japan
,
Kanoko Umezawa1 Division of Respiratory Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe, Hyogo650-0017, Japan
,
Naoko Katsurada1 Division of Respiratory Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe, Hyogo650-0017, JapanORCID Iconhttps://orcid.org/0000-0002-9401-466X
ORCID Icon,
Masatsugu Yamamoto1 Division of Respiratory Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe, Hyogo650-0017, JapanORCID Iconhttps://orcid.org/0000-0003-0596-555X
ORCID Icon,
Kenji Sekiguchi2 Division of Neurology, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe, Hyogo650-0017, Japan
,
Kazuyuki Kobayashi1 Division of Respiratory Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe, Hyogo650-0017, Japan
&
Yoshihiro Nishimura1 Division of Respiratory Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe, Hyogo650-0017, Japan
 show all
Pages 1283-1289 | Published online: 01 Nov 2019

References

  • Sawcer S, Franklin RJ, Ban M. Multiple sclerosis genetics. Lancet Neurol. 2014;13:700–709. doi:10.1016/S1474-4422(14)70041-924852507
  • Osoegawa M, Kira J, Fukazawa T, et al. Temporal changes and geographical differences in multiple sclerosis phenotypes in Japanese: nationwide survey results over 30 years. Mult Scler. 2009;15:159–173. doi:10.1177/135245850809837218987106
  • Compston A, Coles A. Multiple sclerosis. Lancet. 2008;372:1502–1517. doi:10.1016/S0140-6736(08)61620-718970977
  • Polman CH, O’Connor PW, Havrdova E, et al. A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis. N Engl J Med. 2006;354:899–910. doi:10.1056/NEJMoa04439716510744
  • Ransohoff RM. Natalizumab for multiple sclerosis. N Engl J Med. 2007;356:2622–2629. doi:10.1056/NEJMct07146217582072
  • Katz Sand I. Classification, diagnosis, and differential diagnosis of multiple sclerosis. Curr Opin Neurol. 2015;28:193–205. doi:10.1097/WCO.000000000000020625887774
  • Goodin DS, Reder AT, Ebers GC, et al. Survival in MS: a randomized cohort study 21 years after the start of the pivotal IFNβ-1b trial. Neurology. 2012;78:1315–1322. doi:10.1212/WNL.0b013e3182535cf622496198
  • Spelman T, Kalincik T, Zhang A, et al. Comparative efficacy of switching to natalizumab in active multiple sclerosis. Ann Clin Transl Neurol. 2015;2:373–387. doi:10.1002/acn3.18025909083
  • Bergvall N, Makin C, Lahoz R, et al. Relapse rates in patients with multiple sclerosis switching from interferon to fingolimod or glatiramer acetate: a US claims database study. PLoS One. 2014;9:e88472. doi:10.1371/journal.pone.008847224516663
  • Abbas M, Lalive PH, Chofflon M, Simon HU, Chizzolini C, Ribi C. Hypereosinophilia in patients with multiple sclerosis treated with natalizumab. Neurology. 2011;77:1561–1564. doi:10.1212/WNL.0b013e318233b39121975205
  • de Masson A, Maillart E, Veziris N, Meyssonnier V, Papeix C, Caumes E. Cavitary pulmonary disease in a patient treated with natalizumab. Presse Med. 2014;43:1009–1012. doi:10.1016/j.lpm.2013.12.01224742610
  • Hradilek P, Zeman D, Tudik I, Zapletalova O, Ulmann V. Asymptomatic lung disease caused by Mycobacterium kansasii as an opportunistic infection in a patient treated with natalizumab for relapsing-remitting multiple sclerosis. Mult Scler. 2014;20:639–640. doi:10.1177/135245851350157223959714
  • Dahdaleh D, Altmann DM, Malik O, Nicholas RS. Breathlessness, night sweats, and weight loss on natalizumab. Lancet. 2012;380:726–727. doi:10.1016/S0140-6736(12)61401-922920745
  • Almeida KJ, Barreto-Soares RV, Campos-Sousa RN, Campos-Sousa MG, Bor-Seng-Shu E. Pulmonary paracoccidioidomycosis associated with the use of natalizumab in multiple sclerosis. Mult Scler. 2018;24:1002–1004. doi:10.1177/135245851876309129649930
  • Parisinos CA, Lees CW, Wallace WA, Satsangi J. Sarcoidosis complicating treatment with natalizumab for Crohn’s disease. Thorax. 2011;66:1109–1110. doi:10.1136/thx.2010.15576221233484
  • Curto E, Munteis-Olivas E, Balcells E, Domínguez-Álvarez MM. Pulmonary eosinophilia associated to treatment with natalizumab. Ann Thorac Med. 2016;11:224–226. doi:10.4103/1817-1737.18576227512514
  • Bartal C, Sagy I, Barski L. Drug-induced eosinophilic pneumonia: A review of 196 case reports. Medicine (Baltimore). 2018;97:e9688. doi:10.1097/MD.000000000000968829369189
  • Jin F, Wang ST. Chronic eosinophilic pneumonia after trastuzumab and radiation therapy for breast cancer: a case report. Medicine (Baltimore). 2019;98:e14017. doi:10.1097/MD.000000000001401730608451
  • Camus P, Fanton A, Bonniaud P, Camus C, Foucher P. Interstitial lung disease induced by drugs and radiation. Respiration. 2004;71:301–326. doi:10.1159/00007963315316202
  • Cottin V. Eosinophilic lung diseases. Clin Chest Med. 2016;37:535–556. doi:10.1016/j.ccm.2016.04.01527514599
  • Lambrecht BN, Hammad H, Fahy JV. The cytokines of asthma. Immunity. 2019;50:975–991. doi:10.1016/j.immuni.2019.03.01830995510
  • Marchand E, Etienne-Mastroianni B, Chanez P, Lauque D, Leclerc P, Cordier JF. Idiopathic chronic eosinophilic pneumonia and asthma: how do they influence each other? Eur Respir J. 2003;22:8–13. doi:10.1183/09031936.03.0008560312882444
  • Leslie C, Paul A. Patterson’s Allergic Diseases. 7th ed Wolters Kluwer Health;2009: 239–314.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.